Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 4 Apr 23 424B3 Prospectus supplement
- 28 Mar 23 EFFECT Notice of effectiveness
- 24 Mar 23 POS AM Prospectus update (post-effective amendment)
- 18 Jan 22 EFFECT Notice of effectiveness
- 10 Jan 22 POS AM Prospectus update (post-effective amendment)
- 13 Nov 20 EFFECT Notice of effectiveness
- 3 Nov 20 S-1/A IPO registration (amended)
- 13 Oct 20 S-1/A IPO registration (amended)
- 13 Aug 20 S-1/A IPO registration (amended)
-
17 Jul 20 S-1/A IPO registration (amended)
- 26 Jun 20 S-1/A IPO registration (amended)
- 13 May 20 S-1 IPO registration
PPCB similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We hereby consent to the use of our report dated October 15, 2019, on the consolidated financial statements of Propanc Biopharma, Inc. and Subsidiary for the years ended June 30, 2019 and 2018, included herein on the registration statement of Propanc Biopharma, Inc. on Amendment No. 2 to Form S-1, and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ Salberg & Company, P.A.
SALBERG & COMPANY, P.A.
Boca Raton, Florida
July 16, 2020